Davenport & CO LLC Neu Base Therapeutics, Inc. Put Options Transaction History

Davenport & CO LLC

  • $15.7 Billion
  • Q1 2024

Put Options

1 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2021

Jul 21, 2021
BUY
$4.63 - $7.34 $263,910 - $418,380
57,000 New
57,000 $273,000

About NeuBase Therapeutics, Inc.

NBSE Quotes by TradingView
  • Ticker NBSE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,258,700
  • Description
  • NeuBase Therapeutics, Inc., a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as ...
More about NBSE
Track This Portfolio

Track Davenport & CO LLC Portfolio

Follow Davenport & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davenport & CO LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email